These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 705407)

  • 21. [ON THE ORIGIN OF THE ERYTHROCYTIC THROMBOPLASTIC FACTOR].
    KUZNIK BI; NAUMOV AD
    Vopr Med Khim; 1964; 10():140-4. PubMed ID: 14231597
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombocytic complications in a patient with an inhibitor against the contact factor].
    Papaian LP; Litmanovich KIu
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):56-9. PubMed ID: 1273067
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces.
    Tillman B; Gailani D
    Semin Thromb Hemost; 2018 Feb; 44(1):60-69. PubMed ID: 28898903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 25. Coagulation factor XIIa (activated Hageman factor) inhibitor from adult Schistosoma mansoni.
    Tsang VC; Hubbard WJ; Damian RT
    Am J Trop Med Hyg; 1977 Mar; 26(2):243-7. PubMed ID: 848647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemostatic abnormalities in chronic aggressive hepatitis and liver cirrhosis.
    Ruggiero G; De Biasi R; Attanasio S; Bile G; Giusti G
    Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):221-8. PubMed ID: 1179944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturally occurring anticoagulants: a case report.
    Ross SA
    N Z Med J; 1968 Mar; 67(430):411-3. PubMed ID: 4968117
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of alkaline and acid phosphatases on clotting: Evidence that alkaline phosphatase enhances activation of factor IX by SF, and that acid phosphatase enhances plasmatic anti-SF.
    Iatridis PG; Ferguson JH
    Thromb Diath Haemorrh; 1966 May; 15(3):365-80. PubMed ID: 5989024
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgE-induced blood coagulation alterations in the rabbit: consumption of coagulation factors XII, XI, and IX in vivo.
    Pinckard RN; Tanigawa C; Halonen M
    J Immunol; 1975 Aug; 115(2):525-32. PubMed ID: 50367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Circulating anticoagulants in disseminated lupus erythematosus. Apropos of 3 cases].
    Krulik M; Tobelem G; Audebert AA; Mougeot-Martin M; Debray J
    Ann Med Interne (Paris); 1977 Jan; 128(1):57-62. PubMed ID: 855970
    [No Abstract]   [Full Text] [Related]  

  • 32. The contact phase of coagulation in the presence of heparin.
    BLOOM AL
    J Clin Pathol; 1962 Nov; 15(6):508-10. PubMed ID: 13971779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major inhibitors of the contact phase coagulation factors.
    Schapira M
    Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of factors XII and XI in thrombogenesis.
    Nossel HL
    Bull N Y Acad Med; 1972 Feb; 48(2):281-8. PubMed ID: 4257979
    [No Abstract]   [Full Text] [Related]  

  • 35. Study on the correlation between Normotest, Quick's method, and specific coagulation factors in liver disease.
    Hadchouel P; Touboul JP; Caroli J
    Scand J Gastroenterol Suppl; 1973; 19():151-4. PubMed ID: 4515639
    [No Abstract]   [Full Text] [Related]  

  • 36. HAEMORRHAGIC DIATHESIS AS THE RESULT OF SEVERE DEFICIENCY OF PLASMA THROMBOPLASTIN ANTECEDENT (PTA, FACTOR XI).
    DE VRIES SI; BRAAT-VANSTRAATEN MA
    Thromb Diath Haemorrh; 1964 Apr; 11():166-86. PubMed ID: 14167100
    [No Abstract]   [Full Text] [Related]  

  • 37. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation.
    de Araújo RM; Vaz AF; Santos ME; Zingali RB; Coelho LC; Paiva PM; Correia MT; Oliva ML; Ferreira RS
    Thromb Res; 2011 Oct; 128(4):395-7. PubMed ID: 21752431
    [No Abstract]   [Full Text] [Related]  

  • 38. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants.
    Andrew M; Karpatkin M
    J Pediatr; 1982 Oct; 101(4):610-2. PubMed ID: 7119968
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface.
    Altman R; Rouvier J; Reussi C
    Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.